ANTXRL
Anthrax toxin receptor-like
Also known as: ANTRL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NF34
- Gene
- ANTXRL
- Ensembl
- ENSG00000274209
- Chromosome
- 10
- Canonical length
- 631 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable transmembrane signaling receptor activity. Predicted to be located in membrane. Predicted to be active in cell surface and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
631 residues, UniProt reviewed canonical sequence.
>A6NF34|ANTXRL
1 MGSHESLGPY FLVFLLLLLL PPPLFRAGSL RYHGPDWRIF HRLALGSRRA HHHHGPGWRQ
61 HWRQGQAGHR CQGSFDLYFI LDKSGSVNNN WIDLYMWVEE TVARFQSPNI RMCFITYSTD
121 GQTVLPLTSD KNRIKNGLDQ LQKIVPDGHT FMQAGFRKAI QQIESFNSGN KVPSMIIAMT
181 DGELVAHAFQ DTLREAQKAR KLGANVYTLG VADYNLDQIT AIADSPGHVF AVENGFKALR
241 STIDALTSKV CLDVTSVEPS SECVGEPYHV VIHGNGFQNL KKRDEVICRF IFNESTIIDE
301 KPTSIDNNSM NCPGPKLEKP GEEYSIEVSL NKGKTFFKSN VSITSTTCGI FRNWLYFVPL
361 LLLVPLLLCC VWRLCRKQTV KEPPPVQKPE KEPEQEKPPS PPPPPPPPPP PLPPPPPAPV
421 NTCPTVIICC CGCQGVGGMR RIEGNLDTFC DLSHASCHQV PWMCCQSRDQ GRYLSLALAQ
481 SQYAQAPCCP RICFPHSQEC LSLPQAPCSP RMCLRHSREC LALKQARCSP NICLRHSQHS
541 RECLARKQAP CSPRICLRHS PEYFSQAQTL CNPKSCLQPS RECLPLTCSS RCRLPPARCL
601 RPPSRMLPLL SPLLRHTAEP PLSLPPSEPN FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANTXRL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- testis: 12 nTPM
- bone marrow: 0.9 nTPM
- fallopian tube: 0.3 nTPM
- breast: 0.2 nTPM
- cervix: 0.1 nTPM
- endometrium: 0.1 nTPM
Single-cell type
- early spermatids: 71 nCPM
- late spermatids: 50 nCPM
- late primary spermatocytes: 41 nCPM
- sertoli cells: 20 nCPM
- neutrophil progenitors: 5.4 nCPM
- epicardial cells: 2.3 nCPM
Immune cell
- neutrophil: 1.1 nTPM
- basophil: 0.5 nTPM
- eosinophil: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- medulla oblongata: 0.6 nTPM
- white matter: 0.4 nTPM
- pons: 0.3 nTPM
- thalamus: 0.3 nTPM
- basal ganglia: 0.2 nTPM
- cerebellum: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.35
- DepMap mean gene effect
- -0.27
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANTXRL as an antibody target. Whether an autoantibody or antibody against ANTXRL could matter depends on whether native ANTXRL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANTXRL is annotated at the cell surface, where native ANTXRL is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ANTXRL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...